TransMedics Group, Inc. (TMDX)

Every figure this model derived for TMDX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 66,887,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 518,810,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 651,124,000 AssetsCurrent 2026-06-30
current liabilities 98,283,000 LiabilitiesCurrent 2026-06-30
equity 518,053,000 StockholdersEquity 2026-06-30
interest expense 21,240,000 InterestExpenseNonoperating 2026-06-30
ocf 145,928,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 668,468,000 Revenues 2026-06-30
sbc 37,089,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up TMDX on one particular measure came for.

RatioValue
cash operating margin23.21
current ratio6.84
current ratio reported6.62
deferred revenue growth99.36
dilution pct15.13
ebit yoy6.57
fcf margin11.82
growth cv0.72
interest cover3.84
net debt ebitda2.57
operating margin12.21
owner earnings margin6.28
revenue growth25.82
revenue growth per share9.29
roic7.85
rpo growth100.0
rule of 4038.03
sbc pct revenue5.55

What to be careful about

What this model itself distrusts about TMDX's figures. Written by the derivation as it ran, not added afterwards.